VANGUARD CAPITAL WEALTH ADVISORS – Arrowhead Pharmaceuticals, Inc. Transaction History
VANGUARD CAPITAL WEALTH ADVISORS portfolio value:
$292,000
portfolio value
VANGUARD CAPITAL WEALTH ADVISORS quarter portfolio value change:
-6.13%
quarter
Arrowhead Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.28% | -300 shares | -29K | $33.05 | 8.83K |
| Q2 2022 | share | Decrease | -1.08% | -100 shares | -103K | $35.21 | 9.13K |
| Q1 2022 | share | Decrease | -8.10% | -814 shares | -242K | $45.99 | 9.23K |
| Q4 2021 | share | Decrease | -7.80% | -850 shares | -14K | $67.35 | 10.04K |
| Q3 2021 | share | Increase | +0.93% | 100 shares | -214K | $62.43 | 10.89K |
| Q2 2021 | share | Decrease | -2.70% | -300 shares | 190.43K | $82.82 | 10.79K |
| Q1 2021 | share | Decrease | -9.39% | -1.15K shares | -244.43K | $66.31 | 11.09K |
| Q4 2020 | share | Decrease | -12.19% | -1.7K shares | 346K | $76.73 | 12.24K |
| Q2 2020 | share | Decrease | -29.85% | -5.93K shares | -659K | $43.19 | 13.94K |
| Q4 2019 | share | Decrease | -9.04% | -1.97K shares | 646K | $63.43 | 19.88K |
| Q3 2019 | share | Decrease | -7.22% | -1.7K shares | -9K | $28.18 | 21.85K |
| Q2 2019 | share | Decrease | -7.92% | -2.02K shares | 155K | $26.5 | 23.55K |
| Q1 2019 | share | 0.00% | 0 shares | 152K | $18.35 | 25.58K | |
| Q4 2018 | share | Decrease | -3.76% | -1K shares | -192K | $12.42 | 25.58K |
| Q3 2018 | share | Decrease | -12.22% | -3.7K shares | 98K | $19.17 | 26.58K |
| Q2 2018 | share | Decrease | -4.72% | -1.5K shares | 197.41K | $13.6 | 30.28K |
| Q1 2018 | share | Decrease | -1.55% | -500 shares | 94.78K | $7.21 | 31.78K |
| Q4 2017 | share | Increase | 0.00% | 32.28K shares | 118.80K | $3.68 | 32.28K |